Evidence map›Paper›PMID 31932713›Full record

ArticleNature microbiology2020

Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance.

Xianding Deng, Asmeeta Achari, Scot Federman, Guixia Yu, Sneha Somasekar, Inês Bártolo, Shigeo Yagi, Placide Mbala-Kingebeni, Jimmy Kapetshi, Steve Ahuka-Mundeke and 30 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Nature microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 108 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 1 pooled it
25.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 1 synthesis or guideline pooled it, 192 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Development and genomic characterization of a diverse HIV-1 variant reference panel for nucleic acid-based testing.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2026
    Article
  6. Article
  7. Integrating metagenomics and metatranscriptomics intoThe Journal of general virology · 2026
    Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

40 authors at 16 institutions in 7 countries.

Xianding DengDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Asmeeta AchariDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Scot FedermanDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Guixia YuDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Sneha SomasekarDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Inês BártoloResearch Institute for Medicines, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal.
Shigeo YagiViral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, CA, USA.
Placide Mbala-KingebeniInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Jimmy KapetshiInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Steve Ahuka-MundekeInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Jean-Jacques Muyembe-TamfumInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Asim A AhmedBoston Children's Hospital, Boston, MA, USA.
Vijay GaneshMassachussetts General Hospital, Boston, MA, USA.
Manasi TamhankarDepartment of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX, USA.
Jean L PattersonDepartment of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX, USA.
Nicaise NdembiInstitute for Human Virology Nigeria, Abuja, Nigeria.
Dora MbanyaUniversite de Yaoundé I, Yaoundé, Cameroon.
Lazare KaptueUniversité des Montagnes, Bangangté, Cameroon.
Carole McArthurUniversity of Missouri-Kansas City, Kansas City, MO, USA.
José E Muñoz-MedinaInstituto Mexicano del Seguro Social, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-1289-4457
Cesar R Gonzalez-BonillaInstituto Mexicano del Seguro Social, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-2225-5069
Susana LópezInstituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Mexico.ORCID http://orcid.org/0000-0001-6336-9209
Carlos F AriasInstituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Mexico.ORCID http://orcid.org/0000-0003-3130-4501
Shaun ArevaloDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Steve MillerDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Mars StoneBlood Systems Research Institute, San Francisco, CA, USA.
Michael BuschBlood Systems Research Institute, San Francisco, CA, USA.
Kristina HsiehViral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, CA, USA.
Sharon MessengerViral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, CA, USA.
Debra A WadfordViral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, CA, USA.
Mary RodgersAbbott Laboratories, Abbott Park, IL, USA.
Gavin ClohertyAbbott Laboratories, Abbott Park, IL, USA.
Nuno R FariaDepartment of Zoology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-9747-8822
Julien ThézéDepartment of Zoology, University of Oxford, Oxford, UK.
Oliver G PybusDepartment of Zoology, University of Oxford, Oxford, UK.
Zoraima NetoAngolan National Institute of Health Research, Luanda, Angola.
Joana MoraisAngolan National Institute of Health Research, Luanda, Angola.
Nuno TaveiraResearch Institute for Medicines, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal.
John R HackettAbbott Laboratories, Abbott Park, IL, USA.
Charles Y ChiuDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA. charles.chiu@ucsf.edu.ORCID http://orcid.org/0000-0003-2915-2094
University of California, San Francisco · USCalifornia Department of Public Health · USNational Institute of Biomedical Research · CDAbbott Fund · USUniversity of Oxford · GBBlood Systems Research Institute · USMexican Social Security Institute · MXTexas Biomedical Research Institute · USUniversidad Nacional Autónoma de México · MXUniversity of Lisbon · PTBoston Children's Hospital · USMassachusetts General Hospital · USUniversité des Montagnes · CMUniversité de Yaoundé I · CMUniversity of Maryland, Baltimore · USUniversity of Missouri–Kansas City · US

Funding

Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious AgentsR01HL105704 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHIU, CHARLES YEN · 2011 to 2020
$5.9M
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore SequencingR33AI120977 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHIU, CHARLES YEN · 2018 to 2020
$1.6M
Identification of diagnostic and prognostic host biomarkers of Zika virus infection by transcriptome profilingR21AI129455 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHIU, CHARLES YEN · 2017 to 2018
$436k
NHLBI NIH HHS R01 HL105704NIAID NIH HHS R21 AI129455NIAID NIH HHS R33 AI120977Wellcome Trust
6 · The paper itself

Abstract

Metagenomic next-generation sequencing (mNGS), the shotgun sequencing of RNA and DNA from clinical samples, has proved useful for broad-spectrum pathogen detection and the genomic surveillance of viral outbreaks. An additional target enrichment step is generally needed for high-sensitivity pathogen identification in low-titre infections, yet available methods using PCR or capture probes can be limited by high cost, narrow scope of detection, lengthy protocols and/or cross-contamination. Here, we developed metagenomic sequencing with spiked primer enrichment (MSSPE), a method for enriching targeted RNA viral sequences while simultaneously retaining metagenomic sensitivity for other pathogens. We evaluated MSSPE for 14 different viruses, yielding a median tenfold enrichment and mean 47% (±16%) increase in the breadth of genome coverage over mNGS alone. Virus detection using MSSPE arboviral or haemorrhagic fever viral panels was comparable in sensitivity to specific PCR, demonstrating 95% accuracy for the detection of Zika, Ebola, dengue, chikungunya and yellow fever viruses in plasma samples from infected patients. Notably, sequences from re-emerging and/or co-infecting viruses that have not been specifically targeted a priori, including Powassan and Usutu, were successfully enriched using MSSPE. MSSPE is simple, low cost, fast and deployable on either benchtop or portable nanopore sequencers, making this method directly applicable for diagnostic laboratory and field use.

Indexed as

Genome, ViralMetagenomeChikungunya virusComputational BiologyDengueDengue VirusDNA, ViralEbolavirusHemorrhagic Fever, EbolaHigh-Throughput Nucleotide SequencingHumansMetagenomicsPolymerase Chain ReactionRNA, ViralVirus DiseasesVirusesDNA, ViralRNA, Viral

Identifiers

PMID31932713
PMCPMC7047537
OpenAlexW2999983020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.